Clinical trials

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.

Could weight management replace medication as the first line treatment for type II diabetes?

What does analysis of the microbiome literature tell us about priorities and progress in the field?

If prospective registration is enforced for clinical trials, questionable results become easier to spot

Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.

When it comes to identifying cancerous tissue, is the “MasSpec Pen” mightier than the sword?

Are current ethical guidelines for clinical studies letting pregnant women down?

A recent clinical trial finds a new use for an old antibiotic.

Liquid biopsy technology could help boost clinical trial success.

A new treatment for STAT1 mutations has a disappointingly low success rate – but shows potential.